Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 0 | 0 | 0 | 287 | 380 |
| Cost of Goods | N/A | N/A | -380 | 120 | 110 |
| Gross Profit | N/A | N/A | -850 | 160 | 260 |
| Operating Expenses | 481 | 376 | -1,036 | 770 | 950 |
| Operating Income | -481 | -376 | 1,036 | -483 | -570 |
| Interest Expense | -40 | 16 | 37 | 70 | 0 |
| Other Income | 14 | 5 | -1,088 | -7 | -140 |
| Pre-tax Income | -427 | -387 | -89 | -560 | -710 |
| Net Income Continuous | -427 | -387 | -788 | -510 | -710 |
| Net Income Discontinuous | N/A | -689 | -126 | 0 | 0 |
| Minority Interests | N/A | 2 | N/A | N/A | N/A |
| Net Income | $-427 | $-1,078 | $-914 | $-510 | $-710 |
| EPS Basic Total Ops | -0.40 | -2.00 | -1.60 | -0.80 | 0.00 |
| EPS Basic Continuous Ops | -0.40 | -0.66 | -1.35 | -0.80 | -0.06 |
| EPS Basic Discontinuous Ops | N/A | -1.18 | -0.22 | N/A | N/A |
| EPS Diluted Total Ops | -0.40 | -2.00 | -1.60 | -0.80 | 0.00 |
| EPS Diluted Continuous Ops | -0.40 | -0.66 | -1.35 | -0.80 | -0.06 |
| EPS Diluted Discontinuous Ops | N/A | -1.18 | -0.22 | N/A | N/A |
| EBITDA(a) | $-477 | $-376 | $1,089 | $-483 | $-570 |